Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
A clinical trial showed the average GLP-1 client loses between 10% and 15% of their body weight
It also depends on how the numbers are measuredclinical trials report weight loss using different estimands (essentially, different ways of calculating average results), which is why youll sometimes see slightly different percentages for the same study
At therapeutic doses, tirzepatide has shown greater weight loss outcomes in head-to-head trials
3133 Moreover, exenatide itself is teratogen class C and cannot be used in pregnancy
US$ 25.59
US$ 22.78
US$ 22.74
